Leerink Downgrades Akebia Therapeutics (AKBA) to Market Perform

August 7, 2026 6:11 AM

Leerink analyst Roanna Ruiz downgraded Akebia Therapeutics (NASDAQ: AKBA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found